# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-015744
Filing Date
2025-04-25
Accepted
2025-04-25 16:15:48
Documents
20
Period of Report
2025-05-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20042463x2_def14a.htm iXBRL | DEF 14A | 1772009
3 | GRAPHIC | logo_nektar.jpg | GRAPHIC | 14135
4 | GRAPHIC | ny20042463x2_barchart01.jpg | GRAPHIC | 173557
5 | GRAPHIC | ny20042463x2_pvpchart01.jpg | GRAPHIC | 212153
6 | GRAPHIC | ny20042463x2_pvpchart02.jpg | GRAPHIC | 176356
7 | GRAPHIC | ny20042463x2_pc01.jpg | GRAPHIC | 732188
8 | GRAPHIC | ny20042463x2_pc02.jpg | GRAPHIC | 590759
| Complete submission text file | 0001140361-25-015744.txt |  | 7726036

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | nktr-20250523.xsd | EX-101.SCH | 2129
23 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20042463x2_def14a_htm.xml | XML | 330093

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 25874258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)